Loading...
•
Dec 31, 2019
Penumbra Q4 2019 Earnings Report
Penumbra's Q4 2019 financial results were reported, showcasing revenue growth and increased operating income.
Key Takeaways
Penumbra, Inc. reported a 20.3% increase in revenue for the fourth quarter of 2019, reaching $145.3 million. The company's operating income also rose to $10.6 million, compared to $6.7 million in the same period of the previous year. Full year revenue grew by 23.0% to $547.4 million.
Total revenue reached $145.3 million, a 20.3% increase compared to Q4 2018.
Neuro product revenue increased by 15.4% to $85.4 million.
Vascular product revenue grew by 27.9% to $59.8 million.
Operating income increased to $10.6 million, compared to $6.7 million in Q4 2018.
Revenue by Geographic Location
Forward Guidance
Penumbra projects total revenue for 2020 to be in the range of $635 million to $645 million, which represents growth of 16% to 18% over last year. This outlook includes the impact of recent reimbursement changes in Japan. Excluding Japan, Penumbra projects revenue growth for 2020 to be above 20%.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...